Medlive Technology Co., Ltd.

SZSC:2192 Stock Report

Market Cap: HK$6.8b

Medlive Technology Future Growth

Future criteria checks 2/6

Medlive Technology is forecast to grow earnings and revenue by 7.7% and 16.2% per annum respectively. EPS is expected to grow by 6.1% per annum. Return on equity is forecast to be 5.9% in 3 years.

Key information

7.7%

Earnings growth rate

6.1%

EPS growth rate

Healthcare Services earnings growth31.0%
Revenue growth rate16.2%
Future return on equity5.9%
Analyst coverage

Low

Last updated29 Aug 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SZSC:2192 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026834363N/A2303
12/31/2025689317N/A1683
12/31/2024537274N/A1113
6/30/20244822905792N/A
3/31/20244472666397N/A
12/31/202341224269102N/A
9/30/20233842166990N/A
6/30/20233561896979N/A
3/31/20233351536978N/A
12/31/20223141177077N/A
9/30/2022300835157N/A
6/30/2022286483236N/A
3/31/2022285443740N/A
12/31/2021284414244N/A
9/30/2021270557173N/A
6/30/202125570100101N/A
3/31/202123478105106N/A
12/31/202021485110111N/A
12/31/2019122312628N/A
12/31/201883141922N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2192's forecast earnings growth (7.7% per year) is above the savings rate (2.3%).

Earnings vs Market: 2192's earnings (7.7% per year) are forecast to grow slower than the Hong Kong market (11.6% per year).

High Growth Earnings: 2192's earnings are forecast to grow, but not significantly.

Revenue vs Market: 2192's revenue (16.2% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).

High Growth Revenue: 2192's revenue (16.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 2192's Return on Equity is forecast to be low in 3 years time (5.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y